Bioextrax (BIOEX) Stock Overview
Develops and commercializes a bio-based extraction platform technology. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
BIOEX Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
Bioextrax AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 2.45 |
| 52 Week High | SEK 4.00 |
| 52 Week Low | SEK 1.60 |
| Beta | 1.49 |
| 1 Month Change | 5.60% |
| 3 Month Change | -3.92% |
| 1 Year Change | -20.97% |
| 3 Year Change | -42.76% |
| 5 Year Change | -96.55% |
| Change since IPO | -38.75% |
Recent News & Updates
Recent updates
Shareholder Returns
| BIOEX | SE Machinery | SE Market | |
|---|---|---|---|
| 7D | 3.8% | -1.2% | -1.4% |
| 1Y | -21.0% | 26.4% | 12.0% |
Return vs Industry: BIOEX underperformed the Swedish Machinery industry which returned 26.4% over the past year.
Return vs Market: BIOEX underperformed the Swedish Market which returned 12% over the past year.
Price Volatility
| BIOEX volatility | |
|---|---|
| BIOEX Average Weekly Movement | 9.4% |
| Machinery Industry Average Movement | 4.9% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in SE Market | 10.9% |
| 10% least volatile stocks in SE Market | 2.9% |
Stable Share Price: BIOEX's share price has been volatile over the past 3 months compared to the Swedish market.
Volatility Over Time: BIOEX's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 14 | Edvard Hall | bioextrax.com |
Bioextrax AB (publ) develops and commercializes a bio-based extraction platform technology. The company produces PHA (polyhydroxyalkanoates), a group of bio-based and biodegradable bioplastics that replace fossil-based plastics; PHBV, a stiff, high-performance polymer; and PHO, a soft, flexible, and smooth biopolymer with rubbery properties. It also provides hydrolysates protein for animal feed; and keratin microfibers provides insulation, additive and barrier properties for composites, agriculture, filtration, padding, textiles, and more.
Bioextrax AB (publ) Fundamentals Summary
| BIOEX fundamental statistics | |
|---|---|
| Market cap | SEK 116.62m |
| Earnings (TTM) | -SEK 18.57m |
| Revenue (TTM) | SEK 1.02m |
Is BIOEX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BIOEX income statement (TTM) | |
|---|---|
| Revenue | SEK 1.02m |
| Cost of Revenue | SEK 1.06m |
| Gross Profit | -SEK 34.00k |
| Other Expenses | SEK 18.54m |
| Earnings | -SEK 18.57m |
Last Reported Earnings
Jun 30, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.39 |
| Gross Margin | -3.32% |
| Net Profit Margin | -1,813.48% |
| Debt/Equity Ratio | 0% |
How did BIOEX perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/09/13 03:28 |
| End of Day Share Price | 2026/09/11 00:00 |
| Earnings | 2026/06/30 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Bioextrax AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.